Header Logo

Connection

Sean Grimm to Antineoplastic Agents, Alkylating

Back to Details
This is a "connection" page, showing publications Sean Grimm has written about Antineoplastic Agents, Alkylating.
Sean Grimm
Connection Strength
0.148
Antineoplastic Agents, Alkylating
  1. Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro Oncol. 2017 Oct 01; 19(10):1380-1390.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.